HEALTH

NEW YORK — Patients that have been handling their diabetes for a long time are less likely to experience complications, according to a new study conducted by Joslin Diabetes Center researchers.

Among 351 participants in the "Joslin 50-Year Medalist Study," researchers found that among veteran Type 1 diabetics — who have been living with the condition for 50 years or more — 43% were free from advanced diabetic eye complications, while 87% were free from kidney disease, 39% were free from nerve disease and 52% were free from cardiovascular disease.

CLEVELAND — A drug used to treat diabetes also may prevent it, according to a new study published in the journal Experimental Biology and Medicine.

Researchers at Case Western Reserve University took specially bred obese, prediabetic rats and gave them either Merck’s Januvia (sitagliptin), placebo or glyburide, an older diabetes drug. Both of the diabetes drugs lowered blood-glucose levels after the rats had eaten, but only Junuvia raised the total output of insulin by the pancreas while lowering levels of glucagon.

NEW YORK — Johnson & Johnson on April 4 will install Pat Mutchler as head of the McNeil Consumer Healthcare unit, according to a Wednesday evening Associated Press report.

According to the report, Johnson & Johnson said the changes will allow the company to "give focused attention to quality and compliance, and the critical task of restoring McNeil Consumer Healthcare brands."

NEW YORK — The Kardashian matriarch Kris Jenner has signed on to be part of Poise’s “Great Women in History” series, launched last year, to highlight the fact that many great women throughout history have had to contend with light bladder leakage, Poise manufacturer Kimberly-Clark announced Thursday.

NEW YORK — Patients diagnosed with high blood-glucose levels that cannot control the condition over time likely will develop such eye-related complications as retinopathy 10 years later, according to a report in the February issue of Archives of Ophthalmology.

NEW YORK — Graphic Armor, in association with Kiss and Condomania, on Wednesday announced the release of Kiss Kondoms, FDA-approved "picture condoms" featuring a full color image on the latex.

IRVINGTON, N.Y. — Prestige Brands on Wednesday announced the launch of a new one-dose-per-day allergy medicine: PediaCare 24-Hour Allergy.

"We listened to what the moms were looking for: a safe and effective allergy product for their children, ages 2 years and up, that works, has only one dose per day and tastes good," stated Sherry Polevoy, PediaCare senior brand manager. "Parents don't have to worry about redosing during the day, it's dye-free and it's a flavor that kids love: grape."

DANBURY, Conn. — A biopharmaceutical company that specializes in diabetes treatments has appointed a new board chairman.

Biodel said that effective immediately, Brian Pereira, who has served on the drug maker's board since 2007, will become chairman. Current chairman Charles Sanders, who served as chairman since March 2010 after joining the board in August 2006, will continue to serve as a board member, Biodel said.